Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02598336
Other study ID # CIP01/0010
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2011
Est. completion date September 2017

Study information

Verified date July 2018
Source Pneumacare Ltd
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Measurements of Structured Light Plethysmography (SLP) using a chest wall movement based method will be compared to those obtained by spirometry using a flow based pneumotachograph method. This study will enable validation of SLP in children and adults by allowing direct comparison of simultaneous measurements of breathing sequences using the two measurement techniques.

The investigators will also examine, in a group of normal adults, repeatability of the agreement between the two devices, and whether the agreement is affected by a change in tidal breathing parameters.


Description:

Measurements using the Structured Light Plethysmography method will be compared to those obtained by spirometry using a flow based pneumotachograph.

Spirometry is the gold standard for measuring lung function in both clinical support and research roles. Modern spirometers are high precision, reliable instruments enabling a large numbers of parameters relating to lung volumes and the rate of emptying the lungs during a forced expiration to be measured. The most common and accurate method to measure the patient's forced expiration is via pneumotachograph which measures the flow of air through a mouthpiece and integrates the signal to derive the volume expired.

Structured Light Plethysmography (SLP) system that measures changes of the chest and abdominal wall movement during breathing by modelling the thorax and abdominal surface defined by a projected structured light pattern which enables a grid of virtual parts to be formed, the movement of which is recorded by digital cameras. SLP provides non-contact assessment to provide lung function data utilising structured light technologies and enhanced imaging processing.

In this study direct comparison will be made of measurements recorded simultaneously using the two measuring devices in children and adults.

To examine repeatability of the agreement between tidal breathing parameters measured by two techniques, repeated measurements will be performed in each of a group of normal adult subjects. The investigators will also examine whether the agreement is affected by a change in tidal breathing parameters. To obtain a change in tidal breathing parameters, measurements will be recorded during resting spontaneous breathing and after a period of exercise to elevate Respiratory Rate.


Recruitment information / eligibility

Status Completed
Enrollment 41
Est. completion date September 2017
Est. primary completion date January 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Years to 80 Years
Eligibility Inclusion Criteria:

- For the patient group, any patient attending the outpatient department or the Lung Function Laboratory

- For the Healthy Normals group, any adult between 18 and 80 years with no current or previous respiratory condition.

Exclusion Criteria:

- A current cold or other viral infection

- chest surgery within 4 weeks

- Haemoptysis of unknown origin the (forced expiratory manoeuvre may aggravate the underlying condition)

- Pneumothorax

- Unstable respiratory or cardiovascular status (forced expiratory manoeuvre may worsen angina or cause changes in blood pressure) or recent myocardial infarction or pulmonary embolus

- Recent eye surgery

- Presence of an acute disease process that might interfere with test performance (e.g. Nausea, vomiting)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Structured Light Plethysmography
Non contact device that uses light to record displacement of the anterior thorax and abdomen region
Pneumotachograph Spirometry
Device that measures airflow at the mouth using a mouthpiece

Locations

Country Name City State
United Kingdom Cambridge University Hospitals Foundation Trust Cambridge Cambridgeshire

Sponsors (3)

Lead Sponsor Collaborator
Pneumacare Ltd Cambridge University Hospitals NHS Foundation Trust, University of Cambridge

Country where clinical trial is conducted

United Kingdom, 

References & Publications (4)

Bates JH, Schmalisch G, Filbrun D, Stocks J. Tidal breath analysis for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000 Dec;16(6):1180-92. — View Citation

Cala SJ, Kenyon CM, Ferrigno G, Carnevali P, Aliverti A, Pedotti A, Macklem PT, Rochester DF. Chest wall and lung volume estimation by optical reflectance motion analysis. J Appl Physiol (1985). 1996 Dec;81(6):2680-9. — View Citation

Ferrigno G, Carnevali P, Aliverti A, Molteni F, Beulcke G, Pedotti A. Three-dimensional optical analysis of chest wall motion. J Appl Physiol (1985). 1994 Sep;77(3):1224-31. — View Citation

Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R; ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/ American Thoracic Society. Eur Respir J. 2001 Feb;17(2):302-12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Inspiratory over Expiratory flow at 50 percent of tidal displacement (IE50) expressed at a ratio Flow ratios derived from the Respiratory Waveforms 5 minutes
Primary Forced Vital Capacity (FVC) measured in Litres The volume of air a person can exhale during a maximal forced breath 5 minutes
Primary Forced Expiratory Volume in one second (FEV1) measured in litres per second The volume of air a person can exhale in one second during a maximal forced breath 5 minutes
Primary Peak Expiratory Flow (PEF) measured in litres per second The maximal flow a person can achieve during a maximal forced breath 5 minutes
Secondary Respiratory Waveform Visual comparison of respiratory waveform shape and amplitude produced by pneumotachograph and SLP. 5 minutes
Secondary Respiratory Rate (RR) measured in seconds Tmings derived from the Respiratory Waveforms 5 minutes
Secondary Inspiratory Time (tI) measured in seconds Timings derived from the Respiratory Waveforms 5 minutes
Secondary Expiratory Time (tE) measured in seconds Timings derived from the Respiratory Waveforms 5 minutes
Secondary Total breath time (tTot) measured in seconds Timings derived from the Respiratory Waveforms 5 minutes
Secondary Inspiratory/expiratory ratio (tI/tE) expressed as a ratio Timing ratios derived from the Respiratory Waveforms 5 minutes
Secondary The duty cycle (tI/tTot) expressed as a ratio Timing ratios derived from the Respiratory Waveforms 5 minutes
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03572335 - Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
Recruiting NCT06088485 - The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis
Terminated NCT03309358 - A Study of the Safety and Tolerability of Inhaled SNSP113 in Healthy Subjects and Subjects With Stable Cystic Fibrosis Phase 1
Active, not recruiting NCT02504697 - DECAMP-2: Screening of Patients With Early Stage Lung Cancer or at High Risk for Developing Lung Cancer
Completed NCT01443845 - Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) Phase 4
Terminated NCT00524095 - Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis Phase 2
Completed NCT00210249 - Development of an Evaluation Method of Elderly Condition in Patient Receiving Chemotherapy Treatment
Completed NCT00023114 - p450 Mediated Lung Toxicity N/A
Recruiting NCT06056882 - Simultaneous CLE Guided Crybiopsy in Patients With Pulmonary Nodules
Completed NCT03994848 - Incentive Spirometry Prehabilitation Study N/A
Completed NCT00366509 - Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases
Withdrawn NCT05100160 - Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial) Phase 3
Completed NCT03229473 - Fall Risk Assessment in COPD
Recruiting NCT04767074 - A Non-pharmacological Cough Control Therapy N/A
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Completed NCT04996693 - On Dose Efficiency of Modern CT-scanners in Chest Scans N/A
Recruiting NCT04996173 - Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis) N/A
Completed NCT04601545 - The Virtual Reality Therapy as a Pulmonary Rehabilitation Supporting Method N/A
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Recruiting NCT02862418 - Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)